NBC Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$41.8K Sell
108
-7
-6% -$2.6K ﹤0.01% 1353
2026
Q1
$33.7K Sell
115
-21
-15% -$6.9K ﹤0.01% 1483
2025
Q4
$47.7K Buy
136
+1
+0.7% +$338 ﹤0.01% 1382
2025
Q3
$43.6K Sell
135
-15
-10% -$4.67K ﹤0.01% 1391
2025
Q2
$58K Sell
150
-57
-28% -$22.9K ﹤0.01% 1256
2025
Q1
$90K Buy
+207
New +$83.1K 0.01% 1002
2024
Q4
Sell
-1,018
Closed -$529K 1493
2024
Q3
$529K Sell
1,018
-7
-0.7% -$3.74K 0.04% 439
2024
Q2
$555K Buy
1,025
+65
+7% +$34.4K 0.05% 399
2024
Q1
$497K Buy
960
+13
+1% +$6.46K 0.05% 437
2023
Q4
$446K Sell
947
-654
-41% -$302K 0.05% 453
2023
Q3
$697K Buy
+1,601
New +$726K 0.08% 278

Other funds holding ELV

NBC Securities's ELV Position: Q2 2026 in Review

NBC Securities reduced its Elevance Health (ELV) stake by 6.1% in Q2 2026, selling an estimated $2.6K and leaving 108 shares worth $41.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1353.

NBC Securities first reported a position in ELV in Q3 2023 and has held it in 11 quarters since. The position peaked at $697K in Q3 2023. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • NBC Securities held 108 shares of Elevance Health worth $41.8K as of Q2 2026.
  • NBC Securities sold 7 Elevance Health shares in Q2 2026, an estimated $2.6K.
  • Elevance Health made up ﹤0.01% of NBC Securities's portfolio in Q2 2026, its #1353 holding.
  • NBC Securities first reported a position in Elevance Health in Q3 2023 and has held it in 11 quarters since.
  • NBC Securities's Elevance Health position peaked at $697K in Q3 2023.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on NBC Securities's 13F filing for Q2 2026, filed 21 Jul 2026.